Humanized monoclonal antibodies and methods of use
US10179822B2 · kind B2 · utility
1Cited by
20References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2016 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | Nov 11, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises a humanized monoclonal antibody that binds to the human immunoglobulin heavy chain variable region germline gene VH1-69. This antibody is derived from Mab G6 and recognizes the same epitope. Moreover, the antibody is used in combination with vaccines to augment an immune response to the antigen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.